Evidence map›Paper›PMID 27966485›Full record

ArticleJournal of biosciences2016

Metabolic alterations derived from absence of Two-Pore Channel 1 at cardiac level.

Vanessa Garcia-Rua, Sandra Feijoo-Bandin, Maria Garcia-Vence, Alana Aragon-Herrera, Susana B Bravo, Diego Rodriguez-Penas, Ana Mosquera-Leal, Pamela V Lear, John Parrington, Jana Alonso and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of biosciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Two-pore channels: going with the flows.Biochemical Society transactions · 2022
    Article
  3. [Bioinformatics analysis of expression and function of EXD3 gene in gastric cancer].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2019
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Vanessa Garcia-RuaCellular and Molecular Cardiology Research Unit and Department of Cardiology, Institute of Biomedical Research and University Clinical Hospital, 15706, Santiago de Compostela, Spain.
Sandra Feijoo-Bandin
Maria Garcia-Vence
Alana Aragon-Herrera
Susana B Bravo
Diego Rodriguez-Penas
Ana Mosquera-Leal
Pamela V Lear
John Parrington
Jana Alonso
Esther Rosello-Lleti
Manuel Portoles
Miguel Rivera
Jose Ramon Gonzalez-Juanatey
Francisca Lago
Hospital Universitari i Politècnic La Fe · ESUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two-pore channels (TPCs or TPCNs) are novel voltage-gated ion channels that have been postulated to act as Ca2+ and/or Na+ channels expressed exclusively in acidic organelles such as endosomes and lysosomes. TPCNs participate in the regulation of diverse biological processes and recently have been proposed to be involved in the pathophysiology of metabolic disorders such as obesity, fatty liver disease and type 2 diabetes mellitus. Due to the importance of these pathologies in the development of cardiovascular diseases, we aimed to study the possible role of two-pore channel 1 (TPCN1) in the regulation of cardiac metabolism. To explore the cardiac function of TPCN1, we developed proteomic approaches as 2-DE-MALDI-MS and LC-MALDI-MS in the cardiac left ventricle of TPCN1 KO and WT mice, and found alterations in several proteins implicated in glucose and fatty acid metabolism in TPCN1 KO vs. WT mice. The results confirmed the altered expression of HFABP, a key fatty acid transport protein, and of enolase and PGK1, the key enzymes in the glycolytic process. Finally, in vitro experiments performed in neonatal rat cardiomyocytes, in which TPCN1 was silenced using siRNAs, confirmed that the downregulation of TPCN1 gene expression increased 2-deoxy-D-[3H]-glucose uptake and GLUT4 mobilization into cell peripherals in cardiac cells. Our results are the first to suggest a potential role for TPCNs in cardiac metabolism regulation.

Indexed as

AnimalsCalciumCalcium ChannelsCardiovascular DiseasesDiabetes Mellitus, Type 2Fatty Acid Binding Protein 3Fatty Acid-Binding ProteinsGene Expression RegulationGlucose Transporter Type 4HumansLipid MetabolismMiceMice, KnockoutMyocardiumMyocytes, CardiacPhosphoglycerate KinaseCalciumCalcium ChannelsFabp3 protein, mouseFatty Acid Binding Protein 3Fatty Acid-Binding ProteinsGlucose Transporter Type 4Pgk1 protein, mousePhosphoglycerate KinasePhosphopyruvate HydrataseSlc2a4 protein, mouseTPCN1 protein, mouseTwo-Pore Channels

Identifiers

PMID27966485
OpenAlexW2555414968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.